(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CETILAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CETILAR

ST13

US500000079243050

Class

3, 5, 10

Filing

79243050

Registration

5841730

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

01/07/2026

Trademark type

Word

Nice classes

3, 5, 10

Filing date

03/21/2018

Registration date

08/27/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/06/2026

Last transaction

01/07/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

09

Owner location

IT

Examiner

LAVACHE,LINDA M

Current location

Historical data usage

Holders and representatives

Holders

PHARMANUTRA S.p.A.
PHARMANUTRA S.p.A.

Representatives

Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC

Technical classification

Nice Classes

Class 3Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Non-medicated skin creams and hair pomades ; non-medicated skin creams and dermatological pomades; non-medicated skin creams and massage pomades ; cold creams and hair pomades for cosmetic use; cosmetic patchesnon-medicatedscented patches that may be applied on the skin

Class 5

Pharmaceutical preparationspharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regenerationpharmaceutical preparations for skin careanalgesics; dietetic foods adapted for medical use; dietetic substances adapted for medical usedietary supplements; nutritional additives for medical usenutritional supplements; dietetic foodstuffs adapted for medical use; dietetic beverages adapted for medical use; food for babies; dietary and nutritional supplements; dietary and nutritional supplements containing fatty acidsin particular myristic acidmyristoleic acidpalmitoleic acidpalmitic aciddecanoic acid and stearic acid for the treatment of painful articular inflammations and pathologies; dietary and nutritional supplements for oral and for topical use; products for bandages and patchesliquid bandage spraysvitamin supplement patches; medicated patches and transdermal patches for treatment of tendon and muscle injuries and disorders; adhesive bands for medical purposes; dietetic supplements and foods adapted for medical use containing fatty acids (saturated and unsaturated acids)eicosanoid acids and omega 3 acidsdocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA); mineral food supplementsfood supplements and dietetic substances in the nature of dietary supplements not for medical usecontaining vitaminsamino acidsminerals and trace elements; food supplements for medical useincluding fatty acids (saturated and unsaturated acids)eicosanoid acids and omega 3 acidsdocosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA); vitamins and vitamin preparations; all the above mentioned goods are specifically intended for the treatment of inflammations and pathologies both related to articular pain ; adhesive patches being adhesive bandages and bandagesbandages for skin woundssurgical bandages; materials for dressingsmedical and surgical dressings

Class 10

Bandageselastic; supportive patches and bandages for orthopedic use

Publications

History of USPTO decisions and trademark events.

33 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

01/06/2026

71AG

REGISTERED-SEC.71 ACCEPTED

01/06/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/30/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/02/2025

ES71

TEAS SECTION 71 RECEIVED

08/22/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/27/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/15/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/29/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/21/2019

FIMP

FINAL DISPOSITION PROCESSED

12/20/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/27/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

08/27/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/11/2019

PUBO

PUBLISHED FOR OPPOSITION

06/11/2019

GPNX

NOTIFICATION PROCESSED BY IB

06/07/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/22/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/22/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/22/2019

ALIE

ASSIGNED TO LIE

05/06/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/19/2019

RFNP

REFUSAL PROCESSED BY IB

12/08/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/16/2018

RFRR

REFUSAL PROCESSED BY MPU

11/16/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/27/2018

CNRT

NON-FINAL ACTION WRITTEN

10/26/2018

MAFR

APPLICATION FILING RECEIPT MAILED

10/23/2018

DOCK

ASSIGNED TO EXAMINER

10/19/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/19/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/18/2018

Continuous trademark protection

Get notified about every new filing that threatens CETILAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.